| 摘要 |
According to the present invention provided is a compound (1R,2R,3aS,3bS,10aS,10bR,11S,12aS)-10b-fluoro-1-{[(fluoromethyl)sulfanyl]carbonyl}-7-(6-fluoropyridin-3-yl)-11-hydroxy-2,10a,12a-trimethyl-1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl-methoxyacetate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use thereof in therapy. |
